{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "4195733c",
   "metadata": {},
   "source": [
    "## Identify candidate complex words according to corpus frequency"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "c7e878b1",
   "metadata": {},
   "outputs": [],
   "source": [
    "import re\n",
    "import sys\n",
    "import spacy"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "b21c5059",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Load frequency data from corpus (lowercase frequency word list)\n",
    "corpus_freq_list = \"/Users/Leonardo 1/Documents/Trabajo/CORPES-XXI/CORPES_091_fre_general_norm_minusc.txt\"\n",
    "\n",
    "FreqData = {}\n",
    "\n",
    "with open(corpus_freq_list, 'r', encoding=\"utf-8\") as f:\n",
    "    Lines = f.readlines()\n",
    "    for line in Lines:\n",
    "        line.strip()\n",
    "        word, _, freq = re.search(\"^([^\\t]+)\\t([^\\t]+)\\t([^\\t]+)\",line).group(1,2,3)\n",
    "        if word and freq and freq.isdigit() and word not in FreqData.keys():\n",
    "            FreqData[word] = freq\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "1f30fdeb",
   "metadata": {},
   "outputs": [],
   "source": [
    "def get_word_frequency(word, FreqHash):\n",
    "    \n",
    "    ''' Return word frequency from corpus data; if no occurrence in corpus, return 0 '''\n",
    "    \n",
    "    word = word.lower()\n",
    "    \n",
    "    if word in FreqHash.keys():\n",
    "        \n",
    "        return FreqHash[word]\n",
    "    \n",
    "    else:\n",
    "    \n",
    "        return 0\n",
    "    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "8bd5a830",
   "metadata": {},
   "outputs": [],
   "source": [
    "def check_word(word):\n",
    "    \n",
    "    ''' Checks if a word is a digit, contains a punctuaction character or a space due to tokenization error '''\n",
    "    \n",
    "    # Do not check space characters or punctuation signs\n",
    "    exclusion_chars = [\"%\", \"\\n\", \"\\t\", \"≥\", \"≤\", \"/\"]\n",
    "    \n",
    "    # Do not check numbers\n",
    "    if str(word).isdigit():\n",
    "         \n",
    "        return False \n",
    "    \n",
    "    elif word.is_punct:\n",
    "        \n",
    "        return False\n",
    "    \n",
    "    for char in exclusion_chars:\n",
    "        \n",
    "        if (char in word.text):\n",
    "            \n",
    "            return False\n",
    "    \n",
    "    return True\n",
    "    \n",
    "        \n",
    "        "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "000da49f",
   "metadata": {},
   "outputs": [],
   "source": [
    "nlp = spacy.load('es_core_news_md')\n",
    "\n",
    "\n",
    "def sentences_spacy(text, nlp_model):\n",
    "    \n",
    "    ''' Split text into sentences (returns a list) '''\n",
    "    \n",
    "    doc = nlp_model(text)\n",
    "    \n",
    "    Sentences = [sentence for sentence in doc.sents]\n",
    "    \n",
    "    return Sentences\n",
    "\n",
    "\n",
    "def tokenize_spacy(text,nlp_model):\n",
    "\n",
    "    ''' Given a text from an opened file, tokenizes it with Spacy '''\n",
    "    \n",
    "    original_text = text\n",
    "    \n",
    "    doc = nlp_model(text)\n",
    "    \n",
    "    Tokens={}\n",
    "    \n",
    "    for i,token in enumerate(doc):\n",
    "\n",
    "        # Starting offset: token.idx\n",
    "        # Ending offset:\n",
    "        end = str(int(token.idx) + int(len(token.text)))\n",
    "        \n",
    "        Tokens[i] = { 'token': token, 'start': token.idx, 'end': end }\n",
    "        \n",
    "    return Tokens\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "id": "1a9cbb50",
   "metadata": {},
   "outputs": [],
   "source": [
    "texto_prueba = '''Cáncer de próstata grado 2 confirmado histológicamente, tratado con prostatectomía radical (PR). Se podrá incluir a pacientes sin linfadenectomía.'''\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "id": "22bb86ef",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[Cáncer de próstata grado 2 confirmado histológicamente, tratado con prostatectomía radical (PR).,\n",
       " Se podrá incluir a pacientes sin linfadenectomía.]"
      ]
     },
     "execution_count": 28,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "Sentences = sentences_spacy(texto_prueba,nlp)\n",
    "Sentences"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "id": "332e45f2",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Cáncer de próstata grado 2 confirmado histológicamente, tratado con prostatectomía radical (PR).\n",
      "Se podrá incluir a pacientes sin linfadenectomía.\n"
     ]
    }
   ],
   "source": [
    "for sentence in Sentences:\n",
    "    \n",
    "    print(sentence.text)\n",
    "    \n",
    "    Tokens = tokenize_spacy(sentence.text,nlp)\n",
    "    \n",
    "    for t in Tokens:\n",
    "        \n",
    "        token = Tokens[t]['token']\n",
    "\n",
    "        # Do not check numbers, spaces or punctuation signs\n",
    "        if check_word == True:\n",
    "        \n",
    "            freq_value = get_word_frequency(str(token),FreqData)\n",
    "        \n",
    "            # print(token,freq_value,sep=\"\\t\")\n",
    "            # Frequency value as threshold to filter \n",
    "            score = 100\n",
    "            \n",
    "            if (int(freq_value) <= score):\n",
    "                \n",
    "                print(str(token),freq_value,Tokens[t]['start'],Tokens[t]['end'])\n",
    "            "
   ]
  },
  {
   "cell_type": "markdown",
   "id": "9eb1a529",
   "metadata": {},
   "source": [
    "### Processing a document"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "c094073a",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Ensayo prospectivo, aleatorizado, doble ciego, controlado con placebo y multicéntrico de fase IIb para evaluar la eficacia y seguridad del mocravimod como tratamiento adyuvante y de mantenimiento en la leucemia mieloide aguda (LMA) en pacientes adultos sometidos a un trasplante alogénico de células madre hematopoyéticas (TCMH)\n",
      "aleatorizado \tFrecuencia: 59 \tOffsets: 20 32\n",
      "IIb \tFrecuencia: 50 \tOffsets: 94 97\n",
      "mocravimod \tFrecuencia: 0 \tOffsets: 139 149\n",
      "adyuvante \tFrecuencia: 69 \tOffsets: 167 176\n",
      "mieloide \tFrecuencia: 57 \tOffsets: 211 219\n",
      "LMA \tFrecuencia: 51 \tOffsets: 227 230\n",
      "alogénico \tFrecuencia: 13 \tOffsets: 279 288\n",
      "hematopoyéticas \tFrecuencia: 54 \tOffsets: 306 321\n",
      "TCMH \tFrecuencia: 0 \tOffsets: 323 327\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "Ensayo de fase IIb controlado con placebo para evaluar la eficacia y seguridad del mocravimod como tratamiento adyuvante y de mantenimiento en la leucemia mieloide aguda (LMA) en pacientes sometidos a un trasplante alogénico de células madre hematopoyéticas (TCMH) (Estudio Mo-TRANS)\n",
      "IIb \tFrecuencia: 50 \tOffsets: 15 18\n",
      "mocravimod \tFrecuencia: 0 \tOffsets: 83 93\n",
      "adyuvante \tFrecuencia: 69 \tOffsets: 111 120\n",
      "mieloide \tFrecuencia: 57 \tOffsets: 155 163\n",
      "LMA \tFrecuencia: 51 \tOffsets: 171 174\n",
      "alogénico \tFrecuencia: 13 \tOffsets: 215 224\n",
      "hematopoyéticas \tFrecuencia: 54 \tOffsets: 242 257\n",
      "TCMH \tFrecuencia: 0 \tOffsets: 259 263\n",
      "Mo-TRANS \tFrecuencia: 0 \tOffsets: 274 282\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "Indicación científica: Tratamiento adyuvante y de mantenimiento en la TCMH\n",
      "adyuvante \tFrecuencia: 69 \tOffsets: 35 44\n",
      "TCMH \tFrecuencia: 0 \tOffsets: 70 74\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "Criterios de inclusión\n",
      "\n",
      "\n",
      "\n",
      "1.\n",
      "Sujetos con diagnóstico de LMA (excluida la leucemia promielocítica aguda) según la clasificación de 2016 de la Organización Mundial de la Salud (OMS) de la LMA y las neoplasias precursoras relacionadas, incluida la LMA secundaria después de una enfermedad hematológica antecedente (por ejemplo, el síndrome mielodisplásico) y la LMA relacionada con la terapia.\n",
      "LMA \tFrecuencia: 51 \tOffsets: 27 30\n",
      "promielocítica \tFrecuencia: 3 \tOffsets: 53 67\n",
      "LMA \tFrecuencia: 51 \tOffsets: 157 160\n",
      "LMA \tFrecuencia: 51 \tOffsets: 216 219\n",
      "hematológica \tFrecuencia: 18 \tOffsets: 257 269\n",
      "mielodisplásico \tFrecuencia: 2 \tOffsets: 308 323\n",
      "LMA \tFrecuencia: 51 \tOffsets: 330 333\n",
      "\n",
      "\n",
      "2.\n",
      "Sujetos con LMA de alto riesgo según la European LeukemiaNet (ELN) en RC1, LMA de riesgo intermedio en RC1 si MRDpos, o LMA de cualquier riesgo en RC2.\n",
      "LMA \tFrecuencia: 51 \tOffsets: 12 15\n",
      "LeukemiaNet \tFrecuencia: 0 \tOffsets: 49 60\n",
      "RC1 \tFrecuencia: 5 \tOffsets: 70 73\n",
      "LMA \tFrecuencia: 51 \tOffsets: 75 78\n",
      "RC1 \tFrecuencia: 5 \tOffsets: 103 106\n",
      "MRDpos \tFrecuencia: 0 \tOffsets: 110 116\n",
      "LMA \tFrecuencia: 51 \tOffsets: 120 123\n",
      "RC2 \tFrecuencia: 10 \tOffsets: 147 150\n",
      "\n",
      "\n",
      "- La remisión completa se define como: < 5% de blastos en la médula por examen morfológico y ausencia de blastos periféricos circulantes y blastos con bastones de Auer; ausencia de enfermedad extramedular; recuento absoluto de neutrófilos ≥ 1,0x109/L (1000/µL); recuento de plaquetas ≥ 100x109/L (100 000/µL).\n",
      "blastos \tFrecuencia: 8 \tOffsets: 47 54\n",
      "blastos \tFrecuencia: 8 \tOffsets: 105 112\n",
      "blastos \tFrecuencia: 8 \tOffsets: 139 146\n",
      "Auer \tFrecuencia: 3 \tOffsets: 163 167\n",
      "extramedular \tFrecuencia: 4 \tOffsets: 192 204\n",
      "neutrófilos \tFrecuencia: 90 \tOffsets: 227 238\n",
      "1,0x109 \tFrecuencia: 0 \tOffsets: 241 248\n",
      "100x109 \tFrecuencia: 0 \tOffsets: 286 293\n",
      "\n",
      "\n",
      "3.\n",
      "Sujetos que tienen previsto someterse a un TCMH alogénico\n",
      "\n",
      "someterse \tFrecuencia: 0 \tOffsets: 28 37\n",
      "TCMH \tFrecuencia: 0 \tOffsets: 43 47\n",
      "alogénico \tFrecuencia: 13 \tOffsets: 48 57\n",
      "4.\n",
      "Esperanza de vida ≥ 6 meses en el momento de la selección.\n",
      "\n",
      "\n",
      "5.\n",
      "Estado de rendimiento del Eastern Cooperative Oncology Group (ECOG) de 0 o 1.\n",
      "Eastern \tFrecuencia: 32 \tOffsets: 26 33\n",
      "Cooperative \tFrecuencia: 18 \tOffsets: 34 45\n",
      "Oncology \tFrecuencia: 85 \tOffsets: 46 54\n",
      "ECOG \tFrecuencia: 6 \tOffsets: 62 66\n",
      "\n",
      "\n",
      "6.\n",
      "Hombre o mujer, edad ≥ 18 años y ≤ 75 años.\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "Criterios de exclusión\n",
      "\n",
      "\n",
      "\n",
      "1.\n",
      "Uso previsto de globulina antitimocítica (ATG), ciclofosfamida postrasplante, sirolimus, micofenolato mofetilo, abatacept o cualquier medicamento aprobado o no aprobado que no sea MTX más CsA o MTX más TAC para la profilaxis de la EICH.\n",
      "globulina \tFrecuencia: 14 \tOffsets: 16 25\n",
      "antitimocítica \tFrecuencia: 0 \tOffsets: 26 40\n",
      "ATG \tFrecuencia: 3 \tOffsets: 42 45\n",
      "ciclofosfamida \tFrecuencia: 22 \tOffsets: 48 62\n",
      "postrasplante \tFrecuencia: 5 \tOffsets: 63 76\n",
      "sirolimus \tFrecuencia: 8 \tOffsets: 78 87\n",
      "micofenolato \tFrecuencia: 4 \tOffsets: 89 101\n",
      "mofetilo \tFrecuencia: 0 \tOffsets: 102 110\n",
      "abatacept \tFrecuencia: 2 \tOffsets: 112 121\n",
      "MTX \tFrecuencia: 9 \tOffsets: 180 183\n",
      "CsA \tFrecuencia: 64 \tOffsets: 188 191\n",
      "MTX \tFrecuencia: 9 \tOffsets: 194 197\n",
      "EICH \tFrecuencia: 7 \tOffsets: 231 235\n",
      "\n",
      "\n",
      "2.Uso previsto de sueroterapia durante el acondicionamiento, incluyendo ATG y alemtuzumab.\n",
      "2.Uso \tFrecuencia: 1 \tOffsets: 0 5\n",
      "sueroterapia \tFrecuencia: 23 \tOffsets: 18 30\n",
      "ATG \tFrecuencia: 3 \tOffsets: 72 75\n",
      "alemtuzumab \tFrecuencia: 4 \tOffsets: 78 89\n",
      "\n",
      "\n",
      "3.\n",
      "Manipulación ex vivo del injerto principal, incluida la depleción de células T o la selección de CD34+.\n",
      "depleción \tFrecuencia: 62 \tOffsets: 56 65\n",
      "CD34 \tFrecuencia: 7 \tOffsets: 97 101\n",
      "\n",
      "\n",
      "4.\n",
      "Sujetos que hayan recibido un TCMH alogénico previo o receptores de un trasplante de órgano sólido.\n",
      "TCMH \tFrecuencia: 0 \tOffsets: 30 34\n",
      "alogénico \tFrecuencia: 13 \tOffsets: 35 44\n",
      "\n",
      "\n",
      "5.\n",
      "Fármacos inmunosupresores para enfermedades concomitantes.\n",
      "inmunosupresores \tFrecuencia: 56 \tOffsets: 9 25\n",
      "Los sujetos deben poder estar sin prednisona (> 10 mg/día) u otros medicamentos inmunosupresores durante al menos 3 días antes del inicio del tratamiento del estudio.\n",
      "prednisona \tFrecuencia: 36 \tOffsets: 34 44\n",
      "inmunosupresores \tFrecuencia: 56 \tOffsets: 80 96\n",
      "Se permite la dosificación fisiológica de sustitución de hidrocortisona.\n",
      "hidrocortisona \tFrecuencia: 29 \tOffsets: 57 71\n",
      "\n",
      "\n",
      "6.\n",
      "Requerir tratamientos para la disfunción cardíaca\n",
      "\n",
      "7.\n",
      "Sujetos con leucemia promielocítica aguda.\n",
      "promielocítica \tFrecuencia: 3 \tOffsets: 21 35\n",
      "\n",
      "\n",
      "8.\n",
      "Crisis blástica de leucemia mieloide crónica\n",
      "\n",
      "blástica \tFrecuencia: 2 \tOffsets: 7 15\n",
      "mieloide \tFrecuencia: 57 \tOffsets: 28 36\n",
      "9.\n",
      "Disfunción cardíaca\n",
      "\n",
      "\n",
      "10.\n",
      "Disfunción pulmonar.\n",
      "\n",
      "\n",
      "11.\n",
      "Enfermedad hepática significativa o lesión hepática o historia conocida de abuso de alcohol, enfermedad hepática o biliar crónica.\n",
      "Disfunción hepática definida por aspartato aminotransferasa (AST) y/o alanina aminotransferasa (ALT) > 2,5 x límite superior de la normalidad (ULN); o bilirrubina total > 1,5 x ULN\n",
      "aspartato \tFrecuencia: 22 \tOffsets: 33 42\n",
      "aminotransferasa \tFrecuencia: 13 \tOffsets: 43 59\n",
      "AST \tFrecuencia: 49 \tOffsets: 61 64\n",
      "alanina \tFrecuencia: 16 \tOffsets: 70 77\n",
      "aminotransferasa \tFrecuencia: 13 \tOffsets: 78 94\n",
      "ULN \tFrecuencia: 0 \tOffsets: 143 146\n",
      "bilirrubina \tFrecuencia: 95 \tOffsets: 151 162\n",
      "ULN \tFrecuencia: 0 \tOffsets: 177 180\n",
      "\n",
      "\n",
      "12.\n",
      "Disfunción renal con aclaramiento de creatinina < 60 mL/min según la fórmula de Cockcroft-Gault.\n",
      "aclaramiento \tFrecuencia: 38 \tOffsets: 21 33\n",
      "Cockcroft-Gault \tFrecuencia: 2 \tOffsets: 80 95\n",
      "\n",
      "\n",
      "13.\n",
      "Antecedentes de ictus o hemorragia intracraneal en el plazo de 1 año antes la selección.\n",
      "intracraneal \tFrecuencia: 81 \tOffsets: 35 47\n",
      "\n",
      "\n",
      "14.\n",
      "Infección activa clínicamente significativa (vírica, bacteriana o fúngica) que requiera un tratamiento antimicrobiano continuado y que, a juicio del investigador, represente un riesgo para proceder al TCMH.\n",
      "fúngica \tFrecuencia: 40 \tOffsets: 66 73\n",
      "antimicrobiano \tFrecuencia: 79 \tOffsets: 103 117\n",
      "TCMH \tFrecuencia: 0 \tOffsets: 201 205\n",
      "\n",
      "\n"
     ]
    }
   ],
   "source": [
    "with open(\"2021-002864-36.txt\", 'r', encoding='utf8') as f:\n",
    "    \n",
    "    Lines = f.readlines()\n",
    "    \n",
    "    for line in Lines:\n",
    "    \n",
    "        Sentences = sentences_spacy(line,nlp)\n",
    "        \n",
    "        for sentence in Sentences:\n",
    "            \n",
    "            print(sentence.text)\n",
    "    \n",
    "            Tokens = tokenize_spacy(sentence.text,nlp)\n",
    "\n",
    "            for t in Tokens:\n",
    "\n",
    "                token = Tokens[t]['token']\n",
    "                \n",
    "                if check_word(token) == True:\n",
    "                        \n",
    "                    freq_value = get_word_frequency(str(token),FreqData)\n",
    "\n",
    "                    # print(token,freq_value,sep=\"\\t\")\n",
    "                    # Frequency value as threshold to filter \n",
    "                    score = 100\n",
    "\n",
    "                    if (int(freq_value) <= score):\n",
    "\n",
    "                        print(str(token),\"\\tFrecuencia:\",freq_value,\"\\tOffsets:\",Tokens[t]['start'],Tokens[t]['end'])\n",
    "                    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "b477ebe6",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3.7",
   "language": "python",
   "name": "python3-7"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.10"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
